Milestone Pharmaceuticals is trading 5.2% down at $1.09 today, retracing after a sharp 10.6% gain in the previous session despite a lack of new company-specific news.
- The decline appears to be driven by profit-taking following yesterday's rally, as no new regulatory filings or press releases have been issued.
- Sentiment is further weighed down by broader weakness in the healthcare sector, which is currently trading approximately 1.3% lower.
- The price action reflects a mixed broader market environment rather than any fresh fundamental catalysts specific to the company.